Form 4: T2 Biosystems CFO Awarded 360,000 Restricted Stock Units

T2 Biosystems' CFO, John M. Sprague, was granted 360,000 restricted stock units (RSUs) in two tranches, contingent on shareholder approval of an amended incentive plan.

Summary

• T2 Biosystems' CFO, John M. Sprague, received a grant of 360,000 restricted stock units (RSUs).
• The RSUs are split into two grants of 180,000 each.
• The first 180,000 RSUs vest in one installment on May 4, 2025.
• The second 180,000 RSUs vest in three equal annual installments starting November 4, 2025.
• Both grants were contingent on shareholder approval of the amendment and restatement of the company's 2014 Incentive Award Plan.
• Shareholders approved the plan amendment on December 30, 2024.

Sentiment

Score: 7

Explanation: The document reflects a standard compensation practice, which is generally positive for aligning management interests with shareholders. The sentiment is neutral to slightly positive.

Positives

• The grant of RSUs aligns the CFO's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the CFO.

Risks

• The value of the RSUs is dependent on the future performance of T2 Biosystems' stock price.
• There is a risk that the vesting conditions may not be met if the CFO leaves the company before the vesting dates.

Future Outlook

The vesting of the RSUs is tied to future dates, incentivizing the CFO to remain with the company and contribute to its success.

Industry Context

The granting of stock-based compensation is a common practice in the biotechnology industry to attract and retain key executives.

Comparison to Industry Standards

• Stock-based compensation is a standard practice for executive compensation in the biotech industry.
• Companies like Exact Sciences (EXAS) and Bio-Rad Laboratories (BIO) also use RSUs as part of their executive compensation packages.
• The vesting schedule of the RSUs is typical, with some vesting immediately and others vesting over a period of years.

Stakeholder Impact

• Shareholders may view the RSU grant as a positive sign of management's commitment to the company.
• Employees may see the RSU grant as a sign of the company's commitment to its leadership.

Next Steps

• The CFO will receive the first tranche of RSUs on May 4, 2025, if the vesting conditions are met.
• The remaining RSUs will vest in three annual installments starting November 4, 2025.

Key Dates

Keywords

Restricted Stock Units, RSU, Incentive Award Plan, Stock Options, Executive Compensation, T2 Biosystems, TTOO, CFO, John Sprague